Published in Aliment Pharmacol Ther on April 07, 2010
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol (2013) 1.10
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol (2011) 1.00
Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle. World J Gastroenterol (2011) 0.82
Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges. Gastroenterol Res Pract (2013) 0.81
NSAID enteropathy: could probiotics prevent it? J Gastroenterol (2012) 0.81
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol (2016) 0.78
NSAID enteropathy and bacteria: a complicated relationship. J Gastroenterol (2015) 0.78
Small bowel injury in low-dose aspirin users. J Gastroenterol (2014) 0.76
Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats. Gastroenterol Res Pract (2012) 0.75
Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents. World J Gastroenterol (2012) 0.75
Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits. World J Gastroenterol (2016) 0.75
Effect of different antibiotics and non-steroidal anti-inflammatory drugs on the growth of Lactobacillus casei Shirota. Curr Microbiol (2010) 0.75
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09
Systematic review: Sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther (2014) 2.81
Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation (1998) 2.75
The indocyanine green method is equivalent to the ⁹⁹mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. Eur J Surg Oncol (2013) 2.69
The many roles of an RNA editor. Nat Rev Genet (2001) 2.55
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Aneurysmal bone cyst of the mobile spine: report on 41 cases. Spine (Phila Pa 1976) (2001) 2.37
The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology (1990) 2.32
Complications of double balloon enteroscopy: a multicenter survey. Endoscopy (2007) 2.28
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
Screening test for coeliac disease. Lancet (1997) 2.23
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
Detection of malabsorption of low doses of carbohydrate: accuracy of various breath H2 criteria. Gastroenterology (1993) 2.15
Osteoid osteoma. Direct visual identification and intralesional excision of the nidus with minimal removal of bone. J Bone Joint Surg Br (1999) 2.13
Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet (2000) 2.13
Overexpression of folate binding protein in ovarian cancers. Int J Cancer (1997) 2.13
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Aliment Pharmacol Ther (2011) 2.12
Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer (1995) 2.11
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. Neurology (2011) 2.10
Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther (2004) 2.09
Hydrogen peroxide-related colitis (previously known as "pseudolipomatosis"): a series of cases occurring in an epidemic pattern. Endoscopy (2007) 2.07
Atypical sarcoidosis: case reports and review of the literature. Eur Rev Med Pharmacol Sci (2009) 1.98
Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther (2003) 1.88
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.78
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (2006) 1.76
Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol (2000) 1.74
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther (2002) 1.73
Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation (1997) 1.68
Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet (1995) 1.68
Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr (1992) 1.65
Body composition changes induced by chronic ethanol abuse: evaluation by dual energy X-ray absorptiometry. Am J Gastroenterol (2000) 1.63
Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol (1992) 1.62
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci (1998) 1.61
Caudal blockade as alternative therapeutic approach in neonatal arterial thrombosis. Eur J Pediatr (2001) 1.61
Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol (1995) 1.60
Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol (1999) 1.60
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Am J Gastroenterol (2004) 1.59
Late recovery after traumatic, anoxic, or hemorrhagic long-lasting vegetative state. Neurology (2010) 1.59
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther (2003) 1.59
Bone mass and metabolism in patients with celiac disease. Gastroenterology (1995) 1.59
Endoscopic markers in adult coeliac disease. Dig Liver Dis (2002) 1.58
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut (1994) 1.57
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut (2003) 1.56
Methodology of the H2 breath test. II. Importance of the test duration in the diagnosis of carbohydrate malabsorption. Ital J Gastroenterol (1990) 1.55
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.54
Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol (1998) 1.54
Howell-Jolly body counting as a measure of splenic function. A reassessment. Clin Lab Haematol (1990) 1.54
Push-and-pull enteroscopy in the small bowel using the double-balloon technique: results of a prospective European multicenter study. Endoscopy (2005) 1.53
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther (2001) 1.52
Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology (1982) 1.52
Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol (1997) 1.52
Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis. Ital J Gastroenterol Hepatol (1998) 1.50
Cirrhotic cardiomyopathy. Dig Liver Dis (2007) 1.49
Syphilitic aortitis. Catheter Cardiovasc Interv (2001) 1.49
Pitfalls in the determination of absolute dimensions using angiographic catheters as calibration devices in quantitative angiography. Am J Cardiol (1991) 1.45
Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time. Int J Clin Pract (2006) 1.45
Minimally invasive percutaneous fixation in the treatment of thoracic and lumbar spine fractures. Eur Spine J (2009) 1.45
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis (2010) 1.45
Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation (1997) 1.45
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology (1989) 1.43
Coal fly ash as raw material for the manufacture of geopolymer-based products. Waste Manag (2007) 1.42
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Clinical nutrition practice in Italian Gastroenterology Units. Dig Liver Dis (2001) 1.42
Ageing affects anoxia/reoxygenation injury in rat hepatocytes. Scand J Gastroenterol (1998) 1.42
Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia (1995) 1.42
Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study. Ital J Gastroenterol Hepatol (1999) 1.41
Doppler ultrasound evaluation of acute effects of cigarette smoking on portal blood flow in man. J Gastroenterol Hepatol (1996) 1.40
Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis (2005) 1.39
Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn's disease. Eur J Gastroenterol Hepatol (2000) 1.39
Subclinical coeliac disease is a frequent cause of iron-deficiency anaemia. Scand J Gastroenterol (1995) 1.39
Acquired gastric mucosa-associated lymphoid tissue (MALT): a review with special emphasis on association with extragastric diseases and management problems of gastric MALT. J Clin Gastroenterol (1999) 1.38
[Whipple's disease: progress in the diagnosis and review of the literature]. Minerva Med (2002) 1.38
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. Alcohol Clin Exp Res (2000) 1.38
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol (2009) 1.37
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int J Cancer (1998) 1.36
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis (2007) 1.36
DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease. Gut (1985) 1.35